Search research articles
Contact Us
Filters
Showing results (81-90 of 141) with videos related to
Page
of 15
Sort By:
The Oncologist
|
November 27, 2009
CXCR4 expression in early breast cancer and risk of distant recurrence
Fabrice Andre, Weiya Xia, Rosa Conforti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 11, 2017
Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update
Ian Krop, Nofisat Ismaila, Fabrice Andre, et al.
Breast Cancer Research : BCR
|
November 3, 2011
Protein expression, survival and docetaxel benefit in node-positive breast cancer treated with adjuvant chemotherapy in the FNCLCC-PACS 01 randomized trial
Jocelyne Jacquemier, Jean-Marie Boher, Henri Roche, et al.
Cancer Research
|
February 24, 2011
TLR3 as a biomarker for the therapeutic efficacy of double-stranded RNA in breast cancer
Bruno Salaun, Laurence Zitvogel, Carine Asselin-Paturel, et al.
Cancer Treatment Reviews
|
April 17, 2022
Multidisciplinary clinical guidance on trastuzumab deruxtecan (T-DXd)-related interstitial lung disease/pneumonitis-Focus on proactive monitoring, diagnosis, and management
Sandra M Swain, Mizuki Nishino, Lisa H Lancaster, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 11, 2010
Genomic index of sensitivity to endocrine therapy for breast cancer
W Fraser Symmans, Christos Hatzis, Christos Sotiriou, et al.
Autophagy
|
March 17, 2016
The presence of LC3B puncta and HMGB1 expression in malignant cells correlate with the immune infiltrate in breast cancer
Sylvain Ladoire, David Enot, Laura Senovilla, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 2019
Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: ASCO Clinical Practice Guideline Update-Integration of Results From TAILORx
Fabrice Andre, Nofisat Ismaila, N Lynn Henry, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 22, 2023
Comparative Genomic Profiling of Second Breast Cancers following First Ipsilateral Hormone Receptor-Positive Breast Cancers
Elie Rassy, Ingrid Garberis, Alicia Tran-Dien, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 10, 2013
AVEREL: a randomized phase III Trial evaluating bevacizumab in combination with docetaxel and trastuzumab as first-line therapy for HER2-positive locally recurrent/metastatic breast cancer
Luca Gianni, Gilles H Romieu, Michail Lichinitser, et al.
Page
of 15
Search research articles
Search
Showing results (81-90 of 141) with videos related to
Sort By:
Page
of 15
The Oncologist
|
November 27, 2009
CXCR4 expression in early breast cancer and risk of distant recurrence
Fabrice Andre, Weiya Xia, Rosa Conforti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 11, 2017
Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update
Ian Krop, Nofisat Ismaila, Fabrice Andre, et al.
Breast Cancer Research : BCR
|
November 3, 2011
Protein expression, survival and docetaxel benefit in node-positive breast cancer treated with adjuvant chemotherapy in the FNCLCC-PACS 01 randomized trial
Jocelyne Jacquemier, Jean-Marie Boher, Henri Roche, et al.
Cancer Research
|
February 24, 2011
TLR3 as a biomarker for the therapeutic efficacy of double-stranded RNA in breast cancer
Bruno Salaun, Laurence Zitvogel, Carine Asselin-Paturel, et al.
Cancer Treatment Reviews
|
April 17, 2022
Multidisciplinary clinical guidance on trastuzumab deruxtecan (T-DXd)-related interstitial lung disease/pneumonitis-Focus on proactive monitoring, diagnosis, and management
Sandra M Swain, Mizuki Nishino, Lisa H Lancaster, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 11, 2010
Genomic index of sensitivity to endocrine therapy for breast cancer
W Fraser Symmans, Christos Hatzis, Christos Sotiriou, et al.
Autophagy
|
March 17, 2016
The presence of LC3B puncta and HMGB1 expression in malignant cells correlate with the immune infiltrate in breast cancer
Sylvain Ladoire, David Enot, Laura Senovilla, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 2019
Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: ASCO Clinical Practice Guideline Update-Integration of Results From TAILORx
Fabrice Andre, Nofisat Ismaila, N Lynn Henry, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 22, 2023
Comparative Genomic Profiling of Second Breast Cancers following First Ipsilateral Hormone Receptor-Positive Breast Cancers
Elie Rassy, Ingrid Garberis, Alicia Tran-Dien, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 10, 2013
AVEREL: a randomized phase III Trial evaluating bevacizumab in combination with docetaxel and trastuzumab as first-line therapy for HER2-positive locally recurrent/metastatic breast cancer
Luca Gianni, Gilles H Romieu, Michail Lichinitser, et al.
Page
of 15